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Abstract: Black band disease (BBD) of corals is a cyanobacteria-dominated polymicrobial
disease that contains diverse populations of heterotrophic bacteria. It is one of the most
destructive of coral diseases and is found globally on tropical and sub-tropical reefs. We
assessed ten strains of BBD cyanobacteria, and ten strains of cyanobacteria isolated from
other marine sources, for their antibacterial effect on growth of heterotrophic bacteria
isolated from BBD, from the surface mucopolysaccharide layer (SML) of healthy corals,
and three known bacterial coral pathogens. Assays were conducted using two methods:
co-cultivation of cyanobacterial and bacterial isolates, and exposure of test bacteria to
(hydrophilic and lipophilic) cyanobacterial cell extracts. During co-cultivation, 15 of the
20 cyanobacterial strains tested had antibacterial activity against at least one of the test
bacterial strains. Inhibition was significantly higher for BBD cyanobacteria when compared
to other marine cyanobacteria. Lipophilic extracts were more active than co-cultivation
(extracts of 18 of the 20 strains were active) while hydrophilic extracts had very limited
activity. In some cases co-cultivation resulted in stimulation of BBD and SML bacterial
growth. Our results suggest that BBD cyanobacteria are involved in structuring the complex
polymicrobial BBD microbial community by production of antimicrobial compounds.
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1. Introduction
Black band disease (BBD) of corals is known to contribute to the degradation of coral reefs in the
wider Caribbean [1], the Indo-Pacific [2], including the Great Barrier Reef [3], and the Red Sea [4]. It
has been reported to affect 70 species of corals, including both scleractinians and gorgonians [2], and
can cause whole colony mortality by rapid tissue lysis. The disease often targets the ecologically
important reef-framework coral species.
In appearance, BBD is a dark, well-defined cyanobacterial mat that forms a band, which moves
across the coral surface, degrading coral tissue and leaving behind bare coral skeleton. It is a
polymicrobial disease dominated by non-heterocystous filamentous cyanobacteria and contains
populations of sulfate-reducing bacteria, sulfide-oxidizing bacteria, and heterotrophic bacteria. The
BBD microbial community is highly diverse as revealed through microscopy [5,6] and, in particular,
molecular biological methods [7–10].
It has been proposed that some of the BBD microbial diversity may be due to incorporation of coral
surface mucopolysaccharide layer (SML) bacteria into the BBD population [8]. In turn, the presence of
disease may affect the SML bacterial community. Previous studies of coral-associated bacteria
revealed that apparently healthy corals contain less diverse bacterial communities than the healthy
areas of diseased corals, and that the compositions of the two populations are different [7]. While it is
known that coral-associated bacteria are present in coral tissue and skeleton as well as the SML,
studies of the composition of coral-associated bacterial communities have focused on those present in
coral tissue [7,8,11–15], with fewer studies targeting those within the coral SML [10,15,16]. The
results of these studies, in general, indicate that members of the gamma- and alpha-proteobacteria
dominate coral-associated bacterial populations.
The coral probiotic hypothesis [11] proposes that coral resistance to disease can be promoted by
coral-associated bacteria, which prevent colonization by potential pathogens or outcompete pathogens
which may settle on coral. The protective mechanism of coral probiotic bacteria is proposed to include
antibacterial activity, and to date there have been a number of studies aimed at demonstrating that
corals and their associated bacteria possess such properties [16–22]. Koh [18] showed that the alcohol
extract of a large percentage of coral samples had antibacterial activity against a number of heterotrophic
bacteria and cyanobacteria, while results obtained by Kim [20] demonstrated antibacterial activity for
both polar and non-polar (coral-derived) fractions with higher activity associated with non-polar
fractions. In both studies the extracts were prepared from the coral holobiont (the coral animal,
endosymbiotic zooxanthellae, and coral-associated bacteria), and the origin of the active compounds
was not determined. Ritchie [16] found antibacterial activity among the microbial community
associated with the mucus of healthy corals.
Deciphering the relationships among and between the bacterial members of the complex BBD
microbial consortium could provide insight into the etiology of this polymicrobial disease. Since
cyanobacteria are the dominant component of BBD in terms of biomass, we selected this group of
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microorganisms to investigate their ability to inhibit growth of both BBD and (healthy) coral SML
bacterial isolates. In this way, we hypothesize that cyanobacteria may structure the complex BBD
microbial community. We also investigate, for comparison, the antibacterial activity of sub-tropical
marine cyanobacteria from other marine sources. This study assesses the potential of marine
cyanobacteria as a source for novel antibacterial agents that could potentially be applied in human health.
2. Results
2.1. Inhibition of BBD and SML Bacteria during Co-Cultivation with Cyanobacteria
Co-cultivation of BBD and SML bacteria with cyanobacteria revealed that, of the 20 cyanobacterial
strains tested, 15 had antibacterial activity against at least one of the target bacteria. Nine of the BBD
cyanobacterial strains, and six of the other marine cyanobacterial strains, exhibited activity (Figure 1).
Figure 1. Percent of black band disease (BBD) and surface mucopolysaccharide layer
(SML) bacteria inhibited by individual cyanobacterial strains in co-cultivation experiments.
(A) BBD cyanobacteria; (B) other marine cyanobacteria. Note different scales on Y axes.
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Seven BBD cyanobacteria were active against both BBD and SML bacteria, while only three of the
other marine cyanobacteria were active against both groups. Each of the active cyanobacterial strains
from both sources was active against SML bacteria. In contrast, only seven of the nine active BBD and
three of the six active other marine cyanobacterial strains were active against BBD bacteria. Overall,
co-cultivation with BBD cyanobacteria resulted in a higher, statistically significant number of
inhibitions than other marine cyanobacteria (Figure 2).
Figure 2. Inhibition of BBD and SML bacteria by BBD and other marine cyanobacteria in
the co-cultivation experiment. Cyanobacteria from BBD inhibited significantly more
bacteria from both BBD (t-test: P = 0.026) and SML (Mann-Whitney test: P = 0.016) than
other marine cyanobacteria. Error bars = SD (non-transformed data). Asterisks indicate
statistically significant results.

2.2. Interactions between Individual Bacterial and Cyanobacterial Strains
The activity of individual cyanobacterial strains against individual bacterial strains is summarized
in Table 1. This data set includes, in addition to antibacterial activity, cases in which stimulation of
bacterial growth was observed (strain designations bolded). The results of experiments examining both
co-cultivation and exposure to lipophilic extract are summarized. Strain abbreviations designated in
Table 2 as B (BBD), S (SML) and P (known pathogen) were used in Table 1 for ease of comparison of
results for these three categories of test bacteria.
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Table 1. Effect (antibacterial activity and stimulation of growth) of BBD and other marine
cyanobacteria on coral-associated bacteria. Stimulation is indicated in bold. Strain
designations are defined in Table 2.
Bacterial strains inhibited or
stimulated by co-cultivation

Cyanobacteria

Bacterial strains inhibited
by lipophilic extracts

BBD Isolates
BBD 1991
HS 217
HS 223

Geitlerinema
Geitlerinema
Geitlerinema

W-1
FLK BBD1
P2b-2
102a-1
102d-1
96-2
96-4

Geitlerinema
Leptolyngbya
Leptolyngbya
Leptolyngbya
Leptolyngbya
Leptolyngbya
Spirulina

B3, B5, B6, S1, S3, S5, S7, S9, S11
B3, B6, S5, S6, S7, S8, S13
B1, B3, B5, B6, B8, P3, S1, S3, S4, S6,
S7, S9, S13
B6, S6, S7
No effect
B1, B3, B6, S3, S4, S5, S6, S7, S11, S13
B1, B6, S3, S7
S2, S9, S13
B2, B6, S3, S6, S7, S8, S13
S3, S4, S9

B1, B2, B5, B9, B10, P2, P2, S2, S8, S12
P1
B1, B2, B3, B5, B9, B10, P1, P2, S2, S3
B9, B10, S9, S10
B1, B2, B5, B9, P1, P2, S3, S6, S8
B5, B9, S1, S4, S7, S9, S10
B4
B4
No effect
B4, S2, S10

No effect
No effect
No effect
No effect
B1, S2, S8, S9
S6, S7
S4, S5, S9
B3, S4
B1, B2, S2, S4, S5, S9, S10
B1, B2, S5, S9

B2, B3, B4, B5, B9, P1, P2, S2, S4, S8, S12
B9, P2, S4
B5, B9, P1, S12
B5, S12
B1, B4, B5, P2, S1, S2, S4
B5, B10, P2, S4, S9, S10
No effect
B5, B9, B10, P2, S7, S9, S10
B1, B2, B3, B5, B9, P1, P2, S2, S9
B5, B9, B10, S7, S9, S12

Other marine isolates
Alg
10
9-1
HS 26
73-2
63a-5
63-1
72-1
63a-1
63a-3

Leptolyngbya
Leptolyngbya
Leptolyngbya
Leptolyngbya
Phormidium
Pseudanabaena
Pseudanabaena
Pseudanabaena
Synechococcus
Synechococcus

Table 2. Bacterial strains used as target organisms for assessment of the effects of growth
in co-culture with, or exposure to extracts of, BBD and other marine cyanobacteria.
Strain
designation

GenBank closest relative

Accession No. of
closest relative 1

Strain
abbreviation 2

Strains from BBD
HS-216-1a
HS-216-3d
HS-217-1a
HS-217-1c
HS-216-4f
HS-217-2g
HS-216-4g
HS-216-4i
HS-217-2d
HS-216-4a

Vibrio harveyi
Bacillus megaterium
Bacillus cereus
Photobacterium eurosenbergii
Marinobacter sp.
Alteromonas sp.
Marinobacter aquaeolei
Idiomarina sp.
Vibrio harveyi
Methylarcula sp.

AY750576
AJ17381
AY305275
AJ842344
AY196982
AY626838
AJ000726
AB167047
AY750575
AJ534208

B1
B2
B3
B4
B5
B6
B7
B8
B9
B10
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Known coral pathogens
Aurantimonas coralicida
Serratia marcescens
Vibrio shiloi

N/A
N/A
N/A

P1
P2
P3

EU267634
EU781516
EF584057
EU267643
EU070391
FJ461465
DQ995240
EU267643
FJ178079
EF100710
FJ457416
EU276991
EF584084

S1
S2
S3
S4
S5
S6
S7
S8
S9
S10
S11
S12
S13

Strains from healthy corals
1-1
1-2
1-3
1-7
1-8a
1.8b
1-9
1-10
1-11
1-12
1-13
1-14
1-16
1

Vibrio sp.
Alcanivorax sp.
Vibrionaceae
Vibrio sp.
Bacillus sp.
Bacillus sp.
Vibrio harveyi
Vibrio sp.
Vibrio sp.
Vibrio sp.
Vibrio sp.
Vibrio sp.
Vibrio sp.

Strains were 99% similar to the GenBank Accession No. listed with the exception of strains 1-1, 1-7 and 1-10 (100%)

and HS-216-4a (96%);

2

Strain abbreviations used in Table 1. Abbreviations indicate source: B = BBD, S = SML, and

P = known pathogen. N/A = not applicable as known cultures of these strains were used.

Of the 460 combinations tested (20 cyanobacterial strains × 23 bacterial strains), co-cultivation with
cyanobacteria resulted in inhibition in 11% of cyanobacteria/BBD bacteria tests and 18% of
cyanobacteria/SML bacteria tests, with stimulation observed for 1% and 4% respectively (Table 1). In
many cases the same bacterial strain was inhibited by different cyanobacteria. Five of the bacterial
isolates tested (four SML and one BBD) exhibited very high sensitivity to co-cultivation with BBD
cyanobacteria. For example strain B6 (isolate HS-217-2g, identified in GenBank as Alteromonas sp.)
was inhibited by seven of the 10 BBD cyanobacteria. In contrast, none of the other marine
cyanobacteria affected growth of this isolate. Of the SML bacterial isolates, strains S3, S6, S7, and S13
(three Vibrio sp. and one Bacillus—see Table 2) were each inhibited during co-cultivation with five to
seven BBD cyanobacteria (Table 1).
2.3. Activity of Cyanobacterial Extracts
Exposure of test BBD and SML bacteria to lipophilic cyanobacterial extracts (Table 1) resulted in
overall higher inhibition when compared to co-cultivation. There were no cases of growth stimulation.
Lipophilic extracts of nine of the 10 of both BBD and other marine cyanobacteria were active (18 of
the 20 strains). Overall, 23% of BBD bacteria and 26% of SML bacteria exhibited inhibition of growth
after exposure to lipophilic extracts. There was no significant difference in the activity of BBD and
other marine cyanobacteria lipophilic extracts against the BBD and SML bacteria tested (Figure 3).
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Figure 3. Inhibition of BBD and SML bacteria by lipophilic extracts from BBD and other
marine cyanobacteria. There were no significant differences between these two groups of
cyanobacteria. Error bars = SD (non-transformed data).

The lipophilic extracts exhibited much more antimicrobial activity than the hydrophilic extracts,
which in most cases did not have any activity (data not shown). Hydrophilic extracts of only three of
the nine BBD cyanobacteria tested were active, with two strains inhibiting one of the 10 BBD strains
(B1 and B7) and the third inhibiting one SML strain (S8). Hydrophilic extracts of other marine
cyanobacteria did not inhibit any BBD strains, although four of these other marine cyanobacteria
(seven of 10 tested) did inhibit SML bacteria. Of these, three cyanobacteria inhibited one strain and
one cyanobacterium inhibited two strains, with three strains active against S12.
2.4. Activity of Extracts vs. Co-Cultivation with SML and BBD Bacteria
In Table 1, it can be seen that members of all cyanobacterial genera tested exhibited antibacterial
activity, either during co-cultivation or exposure to lipophyllic extracts. The antibacterial activities of
cyanobacterial extracts did not coincide with the results of co-cultivation experiments using the same
cyanobacterial strains. The most dramatic example is the case of the non-BBD Leptolyngbya isolates,
in which none of the co-cultivation experiments yielded any effect whereas lipophilic extracts
inhibited nine strains of BBD bacteria and seven of SML bacteria.
2.5. Antibacterial Activity against Known Coral Pathogens
Only one of the three known coral pathogens tested, Vibrio shiloi (P3 in Table 1), was inhibited by
co-cultivation with cyanobacteria, and only one of the 20 cyanobacterial strains tested (BBD
Geitlerinema HS 223) elicited this result. None of the cyanobacterial extracts elicited growth inhibition
of Vibrio shiloi, and no assay (co-cultivation or extract) elicited stimulation of this pathogen. The other
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two known coral pathogens tested, Aurantimonas coralicida and Serratia marcescens, were affected
(inhibition only) by lipophilic cyanobacterial extracts (Table 1), with no effect observed for the
hydrophilic extracts tested (not shown). Lipophilic extracts of four of the BBD cyanobacterial strains
and three other marine cyanobacterial strains inhibited A. coralicida, while lipophilic extracts of three
BBD cyanobacteria and six other marine cyanobacteria inhibited S. marcescens (Table 1). Overall
there were 16 cases of inhibition of both pathogens, with five of the cyanobacterial strains (including
both BBD and other marine cyanobacteria) inhibiting both A. coralicida and S. marcescens (P1 and
P2 in Table 1).
3. Discussion
In recent years the study of coral-associated microorganisms has greatly expanded, with a focus on
the role of such microorganisms in coral health and disease. A number of these studies have
documented antibacterial activity among and between coral-associated bacteria [16,21], and also
antimicrobial activity of corals themselves [16,22].
Cyanobacteria are well known to produce antibacterial compounds [23–26] and are known to be
associated with corals [8]. However, little work has been done to assess the antibacterial activity of
coral-associated cyanobacteria, or, for that matter, cyanobacteria in other marine environments. In this
work we assessed the activity of marine cyanobacteria on growth of coral-associated bacteria using
two different methods: co-cultivation in which cyanobacterial metabolites were allowed to diffuse into
agar (without breaking their cell walls), and use of extracts prepared from equal amounts of dried
cyanobacterial culture biomass. Our results revealed that co-cultivation of cyanobacteria with BBD or
SML heterotrophic bacteria resulted in 4.8% cases of inhibition of BBD bacteria and 10% cases of
inhibition of SML bacteria. This result was statistically significant for both BBD and other marine
cyanobacteria (P < 0.05; see legend of Figure 2).
Overall, BBD bacteria appear to be more resistant to antibacterial activity of marine cyanobacteria in
general. This might be expected since BBD bacteria live in close physical contact with cyanobacteria.
Within the total BBD bacterial/cyanobacterial test cases, 82% of BBD bacteria exhibited resistance.
However, the 18% that were inhibited were represented by six of the 10 BBD bacterial strains tested.
This result may be important in that the complex BBD microbial community may require small
populations of some functional members; from this perspective, regulation of growth of certain
bacterial members within the organic carbon/nutrient rich BBD environment would be an important
part of the disease etiology.
There was a much higher percentage (30% of test cases) of inhibition of SML bacteria by BBD
cyanobacteria when compared to inhibition of BBD bacteria. This finding suggests that BBD
cyanobacteria may be capable of eliminating potentially beneficial, protective coral-associated
bacteria, thus supporting the coral probiotic hypothesis [11]. Alternatively, BBD cyanobacteria may
eliminate SML bacteria within a developing BBD microbial community to reduce competition. Other
marine cyanobacteria also showed antibacterial activity in 9% of test cases. Therefore, it can be
hypothesized that non-pathogenic cyanobacteria present in healthy corals may also provide protection
against disease-causing microorganisms.
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We observed, to a lesser extent, stimulation of growth of some bacterial isolates during co-cultivation
with cyanobacteria, in particular with other marine cyanobacteria. While there were only two cases of
stimulation by BBD cyanobacteria (both of SML bacteria), there were 10 cases of stimulation by other
marine cyanobacteria. This is in agreement with the findings of Morrow et al. [27] who reported that
two marine Lyngbya species stimulated, but did not inhibit, the growth of marine bacteria.
Antimicrobial activity was found mostly among extracts obtained with non-polar rather than
hydrophilic solvents, which is in agreement with the findings of others [28]. This can be attributed to
the fact that lipophilic compounds more easily cross the cell membrane, thus are more likely to exert
an affect. BBD cyanobacteria appear to produce a variety of antibacterial compounds that are not
excreted, thus their effect on members of the BBD consortium would be limited. We believe that the
co-cultivation experiments more closely mimic the ecological conditions within BBD since
microscopic observations of BBD samples reveal healthy, highly motile cyanobacteria and an absence
of lysing filaments.
Comparison of the coral-associated bacterial isolates used in these experiments with a recently
conducted meta-analysis of 84 BBD bacterial clone libraries [29] revealed that none of our isolates
was a match to BBD sequences deposited from these sources in GenBank. This is not unusual, as
pointed out recently in a study of coral-associated bacteria by Rypien et al. [21] that used a
combination of culture-based and molecular methods. We do note that our test bacteria were
represented by members of three genera, Marinobacter sp., Alteromonas sp., and Vibrio sp., which
have been reported in BBD clone libraries [29]. Of these, the BBD Marinobacter isolate used in the
current study (strain B5) and the Alteromonas isolate (strain B6) were inhibited by two and seven
strains of BBD cyanobacteria respectively (Table 1). Neither was inhibited by other marine
cyanobacteria, and neither was stimulated by any (BBD or other marine) cyanobacterial strain tested.
The Vibrio sp. strains were inhibited to different extents by both BBD and other marine cyanobacteria.
For the known coral pathogens, co-cultivation in only one of the 60 tests (20 cyanobacteria ×
3 bacterial pathogens) resulted in inhibition. This result was obtained for the bacterial bleaching
pathogen Vibrio shiloi. Nissimov et al. [30] found, in an investigation of the antibacterial properties of
bacteria from coral mucus, that 5.7% of bacterial isolates inhibited Vibrio shiloi. Therefore, if this
bacterium is responsible for bleaching of corals under certain environmental conditions, as proposed
by Rosenberg et al. [31], it appears that protection of coral would be not be conferred by
cyanobacterial members of the coral holobiont, and perhaps not by bacterial members.
It was surprising that while co-cultivation did not inhibit growth of the other two coral pathogens
tested (Aurantimonas coralicida and Serratia marcescens) there was inhibition in 27% (16 of 60) of
the tests conducted using lipophilic cyanobacterial extracts. Therefore cyanobacteria (both BBD and
other marine) may potentially be involved in protecting corals from these specific pathogens.
Our results indicate that both pathogenic (BBD) and non-pathogenic marine cyanobacteria can
affect the growth of coral-associated bacteria, and that while most of this activity is manifested as
inhibition of growth, growth stimulation also occurs. While we did not, in the present study, identify
the cyanobacterial compounds responsible for the observed activity, other studies in our laboratory
suggest that at least some of the activity could be due to the cyanotoxin microcystin. We have
previously shown that BBD cyanobacteria produce microcystins [32–34] and that freshly collected
BBD samples contain microcystins [32]. All of the cyanobacteria used in the current study were

Mar. Drugs 2011, 9

2098

previously shown to produce microcystin-LR in the laboratory [33,34], with the exception of two
Leptolyngbya strains that were not tested (strains 96-2 and 9-1; see Table 3). We have also shown that
exposure of healthy coral fragments to low concentrations (1 μg L−1) of purified microcystin-LR
resulted in increased bacterial growth in coral fragments, observed using Scanning Electron
Microscopy [35]. This observation was investigated by exposing bacterial isolates to three
concentrations (1, 100 and 500 μg L−1) of purified microcystin-LR and monitoring growth. These
experiments were carried out using 24 of the 26 bacteria used in the present study (the two strains not
tested were SML strains 1-1 and 1-14, both Vibrio spp.). Results were variable, with microcystin
exposure both inhibiting and stimulating bacterial growth. When comparing the microcystin results with
the results of the current study, only 17% of the cases of inhibition or stimulation by co-cultivation, and
23% of the cases of inhibition or stimulation in response to exposure to lipophilic extracts, were recorded
for strains that responded to microcystin. Separating microcystin effects from other compounds would
require detailed chemical analyses. Another potential source of the active compounds documented in this
study consists of bacteria associated with the non-axenic cyanobacterial cultures. However, we deem
this source to be negligible since all cyanobacteria were grown autotrophically for these experiments,
thus their biomass would be orders of magnitude higher than the contaminants. Microscopic
examination of the cyanobacterial cultures did not reveal the presence of bacteria; they could be
detected only by plating cyanobacteria onto heterotrophic media.
Table 3. Cyanobacterial isolates investigated, taxonomic identification, location of
collection, and source of origin.
Isolate

Closest
relative

Similarity
%

GenBank
access. No.

Location/Source

Reference

Florida Keys, Algae Reef, BBD
on Montastraea annularis
LSI Bahamas, Horseshoe Reef,
BBD on Siderastrea siderea
LSI Bahamas, Horseshoe Reef,
BBD on Siderastrea siderea
Florida Keys, Watson’s Reef,
BBD on Siderastrea siderea
Florida Keys, South Carysfort,
BBD on Montastraea annularis
Philippines, BBD on Porites lutea
Florida Keys, BBD on
Dendrogyra cylindrus
Florida Keys, BBD on
Montastraea annularis
Florida Keys, BBD on
Montastraea annularis
Florida Keys, BBD on
Montastraea annularis

[36]

BBD Isolates
BBD 1991

Geitlerinema 1

99

DQ151461

HS 217

Geitlerinema

99

EF110974

HS 223

Geitlerinema

99

DQ680351

W-1

Geitlerinema

99

EF154084

FLK BBD1 Leptolyngbya

98

EF110975

P2b-2
102a-1

Leptolyngbya
Leptolyngbya

98
97

EF372581
EU743966

102d-1

Leptolyngbya 2

97

EU743968

96-2

Leptolyngbya 3,4

N/A

96-4

Spirulina

93

N/A
EU743969

[37]
[37]
[37]
[37]
[37]
[33]
[33]
This work
[33]
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Other marine isolates
Alg

Leptolyngbya 3,4

10

Leptolyngbya

9-1

Leptolyngbya 3,4

N/A

N/A

HS26

Leptolyngbya

N/A

FJ232376

73-2
63a-5
63-1
72-1

Phormidium
Pseudanabaena
Pseudanabaena 2
Pseudanabaena

97
97
98
98

EU196366
FJ026734
EU110976
EU196365

63a-1
63a-3

Synechococcus 2
Synechococcus

98
98

EU743972
EU743971

1

N/A
99

N/A
FJ232377

Florida Keys, Algae Reef, mat on
sediment
Florida Keys, NN Dry Rocks, mat
on Montastraea cavernosa
Florida Keys, Horseshoe reef, mat
on Colpophyllia natans
Florida Keys, Horseshoe reef, mat
on coral away from BBD
Gulf of Mexico, plankton
Florida Keys, mat on sediment
Florida Keys, mat on sediment
Florida Keys, NN dry rocks, mat
on Montastraea cavernosa
Florida Keys, mat on sediment
Florida Keys, mat on sediment

[33]
[33]
This work
[33]
[38]
[33]
[38]
[38]
[33]
[33]

This strain, identified morphologically as Phormidium was subsequently shown using molecular techniques to belong to

Geitlerinema;

2

These strains were not tested using hydrophilic extracts, see text;

3

Not sequenced;

4

Identified using

classical taxonomic criteria because the BLAST search did not provide a species level identification.

4. Experimental Section
4.1. Source of Cyanobacterial and Bacterial Isolates
Table 3 presents the source and identities of the 20 cyanobacteria investigated in this study. Ten
cyanobacterial strains from BBD, representing members of three cyanobacterial genera, from reefs of
the Florida Keys, Bahamas, and the Philippines, and ten other marine cyanobacterial strains
representing four genera from the Gulf of Mexico and reefs of the Florida Keys, were obtained as
non-axenic uni-algal cultures as previously described [33,37]. The three BBD cyanobacterial genera
have been detected in multiple BBD mats on different reefs of the Caribbean and the Philipines and
from different coral host species [37]. From work by our group and others it appears that specific
cyanobacteria are found in BBD regardless of host or location [7,9,37,39,40] hence our selection
of cyanobacterial isolates from the different sources. The other marine cyanobacteria included
mat-forming, filamentous types and planktonic, unicellular types from sub-tropical reef habitats in
Florida as well as the Gulf of Mexico. All filamentous cyanobacteria were cultured from individual
trichomes and were uni-algal cultures. Accompanying bacteria were closely associated with the
cyanobacterial sheaths. Cultures of unicellular cyanobacterial isolates were axenic.
Heterotrophic bacteria used as test strains were isolated from BBD infections on the host coral
Siderastrea siderea on Horseshoe Reef, Lee Stocking Island, Bahamas (10 strains), and from the SML
of apparently healthy colonies of S. siderea on reefs in the Florida Keys (13 strains), summarized in
Table 2. Unlike BBD cyanobacteria, for which the same 16S rRNA gene sequences are found on
different coral host species and in different geographical regions [37], BBD-associated heterotrophic
bacteria have been shown to be region specific [40]. On the other hand, Caribbean coral-associated
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heterotrophic bacteria have been reported to be coral host species specific [13]. Therefore we selected
test SML bacteria from different colonies of the same coral species (S. siderea) to decrease variability
based on host specificity. Additionally, three known bacterial coral pathogens were tested. These were
Aurantimonas coralicida, Serratia marcescens, and Vibrio shiloi, associated with the coral diseases
white plague type II, white pox, and bacterial bleaching [41–43] respectively, and were available as
previously isolated laboratory cultures.
4.2. Field Sampling
Samples of BBD and the SML of apparently healthy corals were collected, using sterile needleless
10 mL syringes, while SCUBA diving. After collection, samples were maintained at ambient seawater
temperature in darkness until return to the lab. Strains of heterotrophic bacteria were isolated into pure
culture by streaking BBD or SML samples onto Marine Agar (Difco) plates. Inoculated plates were
incubated at room temperature and colonies with different morphologies were picked and replated to
purity. Pure cultures were maintained at room temperature on marine agar slants, while cyanobacterial
cultures were maintained on marine BG11 liquid medium in 125 mL Erlenmeyer flasks at 26 °C, under
a 12:12 h light:dark fluorescent light regime with an intensity of 20 μE m−2 s−1.
Taxonomic identifications were based on 16S rRNA gene sequencing and BLASTN search for the
closest relatives in GenBank. Isolation of total genomic DNA, 16S rRNA gene amplification, and
sequencing were performed as described elsewhere [37,44]. Cyanobacterial strains 96-2, Alg, and 9-1
were not sequenced and their taxonomic identification was based on morphology [45]. The sequence
obtained from strain HS26 was most closely related (97% similarity) to an “uncultured cyanobacterium,
clone Ct-3-39” obtained from coral reef sediments (accession number AM177427 in the GenBank
database). This strain was also identified using classical methods based on morphology [45].
4.3. Co-Cultivation of Cyanobacteria and Heterotrophic Bacteria
One of the two methods used to assess the effect of the cyanobacterial isolates on growth of
heterotrophic bacteria was the co-cultivation method [46]. BG11 agar plates were first overgrown with
a test strain of cyanobacteria, then cut into 7 mm diameter disks which were transferred to empty Petri
plates. Plates were then overlaid with warm Marine Agar and refrigerated overnight to allow diffusion of
metabolites from the disk into the surrounding medium. Subsequently, each plate was spread-inoculated
with one of the test bacteria, each of which had been grown in Marine Broth for 24 h prior to inoculation.
This procedure was carried out for each combination of cyanobacteria-heterotrophic bacteria strains
(20 × 26 = 520) and was carried out in triplicate (1560 individual tests). Plates were incubated at 27 °C
for 48 h after which they were checked for the presence of inhibition zones or enhanced growth
(stimulation). Antibacterial activity was recorded as positive if the zone of inhibition was equal to or
greater than 9 mm in diameter.
4.4. Preparation of Cyanobacterial Extracts
The second method used to assess cyanobacterial/bacterial interactions was based on testing of
cyanobacterial cell extracts. To prepare extracts cyanobacteria were grown in 3-L cultures in marine
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BG11 medium [47] at 28 °C and a light intensity of 30 μE m−2 s−1. Cultures were aerated with sterile
air and harvested after four weeks by centrifugation. The collected biomass was freeze dried and kept
at −20 °C until used for extract preparation as described in [46]. Two types of crude extracts were
prepared, lipophilic and hydrophilic, from each sample. The biomass (100 mg of freeze dried sample
for each cyanobacterial culture) was first extracted with chloroform (lipophilic extract), and then with
30% ethanol (hydrophilic extract). Both extracts were evaporated to dryness, then resuspended in
absolute ethanol and 30% ethanol, respectively, to produce a final concentration of 1 mg of dry residue
per mL of solvent.
4.5. Activity of Cyanobacterial Extracts
The agar diffusion technique was used to test the effect of cyanobacterial extracts on the growth of
bacterial isolates. Wells in Marine Agar plates were made using a sterile glass tube (7 mm diameter)
and filled with 70 μL of extract, with each extract tested in triplicate. Plates were dried in a laminar
flow cabinet. Control plates contained solvent only (100% or 30% ethanol) and had no effect on the
growth of any of the test bacteria. Once the plates were dry (no solvent present in the wells) they
were spread inoculated with 24 h cultures of each of the test bacteria (grown in Marine Broth) and
incubated at 27 °C for 48 h, after which the presence or absence of zones of inhibition, or stimulation
of growth around wells, were recorded. Using this method it was apparent that there was very little
activity of the hydrophilic extracts. Therefore, while the complete set (20 cyanobacteria × 26 bacteria
in triplicate = 1560 assays) of cyanobacteria/bacteria combinations was tested for the lipophilic
extracts, only nine of the 10 BBD cyanobacteria and seven of the 10 other marine cyanobacteria, were
tested (1104 assays). All three known pathogens were also tested. All tests were performed in triplicate.
4.6. Statistical Analysis
To test for statistical significance of results, the percentages of inhibition of bacterial test strains by
each cyanobacterial strain were first transformed to arcsin values. T-tests were used when the data
passed both a Kolmogorov-Smirnov test for normality and a test for equal variance. If they failed a
Mann-Whitney Rank Sum test was used. Statistical software used was SigmaStat ver. 3.5 (Systat
Software, Inc.).
5. Conclusions
Marine environments, including tropical and sub-tropical coral reefs, have served as a source for
novel natural products for decades. It may be that corals, and in particular their associated
microorganisms, are a potential new source for antibacterials and other metabolites that could serve as
biomedical agents with relevance to human health in a manner similar to bioactive compounds derived
from marine sponges. In this study we have shown that cyanobacteria associated with a coral disease,
and also non-pathogenic cyanobacteria from different sub-tropical marine environments, produce
bioactive compounds that suppress the growth of coral-associated bacteria. These results supplement
our earlier work that has shown that coral reef cyanobacteria produce the cyanotoxin microcystin. In
terms of the microbial ecology of coral disease, specifically the subject of our study, black band
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disease, it appears that the cyanobacteria that dominate BBD lesions have an active roll in disease
etiology based on production of the cyanotoxin microcystin, which can cause coral tissue lysis [35],
and antibacterial agents that target bacteria both within the complex BBD polymicrobial disease
consortium and within the protective SML of healthy coral colonies. Thus cyanobacterial toxin and
antibacterial production appear to be integral parts of the pathobiology of this coral disease.
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